Development and evaluation of sustained release of moxifloaxacin ocular formulations for bacterial conjunctivitis and keratitis

dc.contributor.guide	Sharma, Manju
dc.coverage.spatial
dc.creator.researcher	Khurana, Lalit Kumar
dc.date.accessioned	2019-11-05T10:22:47Z
dc.date.available	2019-11-05T10:22:47Z
dc.date.awarded	2019
dc.date.completed	2019
dc.date.registered	2015
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent
dc.identifier.uri	http://hdl.handle.net/10603/262128
dc.language	English
dc.publisher.institution	Department of Pharmacology
dc.publisher.place	Delhi
dc.publisher.university	Jamia Hamdard University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Life Sciences,Immunology,Pharmacology and Pharmacy,Moxifloaxacin, Nanoparticles, Conjunctivitis, Keratitis
dc.title	Development and evaluation of sustained release of moxifloaxacin ocular formulations for bacterial conjunctivitis and keratitis
dc.title.alternative
dc.type.degree	Ph.D.